BioPorto Logo

BioPorto

BIOPOR | CO

Overview

Corporate Details

ISIN(s):
DK0011048619
LEI:
5299004SWFL5JAN4W830
Country:
Denmark
Address:
Tuborg Havnevej 15, st., 2900 Hellerup
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes in patient management. The Company uses its expertise in antibodies and assay development, as well as its platform for assay development, to create a pipeline of novel and compelling products that focus on conditions where there is a significant unmet medical need, and where the Company’s tests can help improve clinical and economic outcomes for patients, providers, and the healthcare ecosystem. The Company’s flagship product is The NGAL Test, which has been designed to aid in the risk assessment of Acute Kidney Injury (AKI), a common clinical syndrome that can have severe consequences, including significant morbidity and mortality if not identified and treated early.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-27 09:19
Regulatory News Service
English 7.4 KB
2025-06-27 09:19
Regulatory News Service
Danish 7.4 KB
2025-06-10 16:19
Board/Management Information
Danish 8.5 KB
2025-06-10 16:19
Board/Management Information
English 7.9 KB
2025-06-10 16:19
Board/Management Information
English 90.8 KB
2025-06-10 16:19
Board/Management Information
Danish 119.0 KB
2025-04-25 13:55
Director's Dealing
English 28.4 KB
2025-04-25 13:55
Director's Dealing
Danish 155.6 KB
2025-04-25 13:55
Director's Dealing
English 133.6 KB
2025-04-25 13:55
Director's Dealing
Danish 28.7 KB
2025-04-25 13:45
Declaration of Voting Results & Voting Rights Announcements
English 84.5 KB
2025-04-25 13:45
Declaration of Voting Results & Voting Rights Announcements
Danish 114.6 KB
2025-04-25 13:45
Declaration of Voting Results & Voting Rights Announcements
English 5.8 KB
2025-04-25 13:45
Declaration of Voting Results & Voting Rights Announcements
Danish 5.7 KB
2025-04-14 16:55
Transaction in Own Shares
English 12.7 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Stayble Therapeutics AB Logo Stayble Therapeutics AB Sweden STABL
Stem Cells Spin Spolka Akcyjna Logo Stem Cells Spin Spolka Akcyjna Poland SCS
Strategic Partners A/S Logo Strategic Partners A/S Denmark STRAP
STRIX GROUP PLC Logo STRIX GROUP PLC Isle of Man KETL
Swedish Orphan Biovitrum Logo Swedish Orphan Biovitrum Sweden SOBI
SynAct Pharma Logo SynAct Pharma Sweden SYNACT
SYNAIRGEN PLC Logo SYNAIRGEN PLC United Kingdom SNG
Synthaverse S.A. Logo Synthaverse S.A. Poland BML
Taurus Energy AB Logo Taurus Energy AB Sweden TAUR B
Themis GREN Ltd. Israel TMIS